Skip to main content

Advertisement

Log in

Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies

  • Original Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Lewy bodies (LBs), the pathological hallmark of Lewy body disease (LBD), contain α-synuclein, as well as other proteins. In this study, we examined the relationship of α-synuclein to two rate-limiting enzymes in neurotransmitter synthesis, tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT). Double-labeling immunohistochemistry for α-synuclein and TH revealed TH immunoreactivity within LBs in catecholaminergic neurons in the substantia nigra and locus coeruleus, but not within LBs in cholinergic neurons in the pedunculopontine nucleus and nucleus basalis of Meynert. In contrast, ChAT immunoreactivity within LBs was detected in cholinergic, but not within LBs in catecholaminergic neurons. The amygdala was devoid of TH and ChAT positive LBs, although a few Lewy neurites contained ChAT immunoreactivity. Further analysis revealed two distinct patterns of neurotransmitter immunoreactivity within LBs. One pattern had diffuse co-localization of TH or ChAT with α-synuclein as in cortical-type LBs, while the other had intense TH or ChAT immunoreactivity in the LB core surrounded by a peripheral rim of α-synuclein as in brainstem-type LBs. Levels of both TH and ChAT were higher in brainstem-type LBs than in the cytoplasm of the same neuron or in neurons from the same case devoid of LBs. Given the fact that LB-containing neurons have decreases in cytoplasmic TH and ChAT immunoreactivity, these results suggest LBs may disrupt cholinergic and catecholaminergic neurotransmitter production by sequestration of the rate-limiting enzymes for acetylcholine and catecholamine synthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277–288

    Article  CAS  PubMed  Google Scholar 

  2. Dickson DW, Davies P, Mayeux R et al (1987) Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol 75:8–15

    Article  CAS  PubMed  Google Scholar 

  3. Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT (2000) alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol 99:352–357

    Article  CAS  PubMed  Google Scholar 

  4. Kosaka K (1978) Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol 42:127–134

    Article  CAS  PubMed  Google Scholar 

  5. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75:345–353

    Article  CAS  PubMed  Google Scholar 

  6. Leverenz JB, Umar I, Wang Q et al (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139–145

    Article  CAS  PubMed  Google Scholar 

  7. Lippa CF, Smith TW, Perry E (1999) Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 106:525–535

    Article  CAS  PubMed  Google Scholar 

  8. Masliah E, Galasko D, Wiley CA, Hansen LA (1990) Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol 80:453–458

    Article  CAS  PubMed  Google Scholar 

  9. Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808–815

    Article  CAS  PubMed  Google Scholar 

  10. Nakano I, Hirano A (1984) Parkinson’s disease: neuron loss in the nucleus basalis without concomitant Alzheimer’s disease. Ann Neurol 15:415–418

    Article  CAS  PubMed  Google Scholar 

  11. Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96

    Article  CAS  PubMed  Google Scholar 

  12. Perry E, Court J, Goodchild R et al (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm 105:915–933

    Article  CAS  PubMed  Google Scholar 

  13. Perry E, Court J, Goodchild R et al (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm 105:915–933

    Article  CAS  PubMed  Google Scholar 

  14. Perry EK, McKeith I, Thompson P et al (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson’s disease, and Alzheimer’s disease. Ann N Y Acad Sci 640:197–202

    CAS  PubMed  Google Scholar 

  15. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183–191

    Article  CAS  PubMed  Google Scholar 

  16. Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61:1915–1919

    Article  PubMed  Google Scholar 

  17. Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M (2008) Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson’s disease is related to disability of the patients. Parkinsonism Relat Disord 14:553–557

    Article  PubMed  Google Scholar 

  18. Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53–65

    CAS  PubMed  Google Scholar 

  19. Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661–1668

    Article  CAS  PubMed  Google Scholar 

  20. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840

    Article  CAS  PubMed  Google Scholar 

  21. Tiraboschi P, Hansen LA, Alford M et al (2000) Cholinergic dysfunction in diseases with Lewy bodies. Neurology 54:407–411

    CAS  PubMed  Google Scholar 

  22. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581–583

    Article  CAS  PubMed  Google Scholar 

  23. Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13:243–248

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Monica Castanedes Casey, David Personett, Linda Rousseau and Virginia Phillips for their histopathological expertise and technical support. The authors would also like to thank Dr. Tanis Ferman for constructive advice. This research would not be possible without brain donations from patients and their families. This study was supported by grants from the National Institutes of Health (R01-AG15866, P50-AG16574, P50-NS40256) and Mayo Foundation for Research & Education.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis W. Dickson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dugger, B.N., Dickson, D.W. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120, 633–639 (2010). https://doi.org/10.1007/s00401-010-0739-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-010-0739-1

Keywords

Navigation